Apr 30, 2018
FLINT, Mich. — April 30, 2018 — The nation’s largest independent provider of specialty pharmacy services unites benefit-management companies to form specialty-focused CastiaRx.
Diplomat Pharmacy, Inc. (NYSE: DPLO), has unveiled CastiaRx to respond to industry demand for a leader in specialty benefit management.
CastiaRx unites the full-service pharmacy benefit manager (PBM) capabilities of recently acquired LDI Integrated Pharmacy Services and National Pharmaceutical Services with Diplomat’s specialty pharmacy and infusion expertise.
According to the the IQVIA Institute for Human Data Science, the late-phase development pipeline recently included more than 800 specialty drugs. The Pharmacy Benefit Management Instituteprojects that more than 50 percent of U.S. drug spend will be specialty by 2020.
Albert Thigpen, president and chief operating officer of CastiaRx, said specialty drugs are life-changing for people with complex diseases—including cancer and rare genetic conditions—but often require more expert support.
“The current PBM model wasn’t designed to address the challenges that come with specialty drugs,” Thigpen said. “While CastiaRx offers traditional PBM services, we also bring broader depth to address the intricacies of specialty pharmacy management—under both the pharmacy and medical benefit. With 24/7 patient support, advanced analytic capabilities, and clinical expertise founded on a centers-of-excellence approach, we can help patients achieve the best possible outcomes.”
Joel Saban, president of Diplomat, said CastiaRx simplifies the patient journey by tailoring support based on the patient’s stage of illness, clinical status, and communication preferences. He said the brand focuses on anticipating member needs, increasing adherence, closing gaps in care, and ultimately enabling better outcomes. CastiaRx offers a range of service levels, with high-touch support for patients who need it and digital tools for those who prefer self-service.
“Managing specialty drug spend is part of our company’s DNA,” Saban said. “We saw tremendous synergies between Diplomat’s longstanding efforts in this area and those of our PBMs. Uniting all this under CastiaRx can relieve the complexity of specialty drug management for small and midsize payers as we provide a true solution to help them prepare for what’s ahead.”
CastiaRx combines 50 years of PBM service with more than 40 years’ experience handling specialty pharmaceuticals.
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance and may include Diplomat’s expectations regarding benefits of business and growth strategies. The forward-looking statements contained in this press release are based on management’s good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. These risks and uncertainties include: our ability to adapt to changes or trends within the specialty pharmacy industry; increasing consolidation in the healthcare industry; our ability to successfully integrate acquired businesses; and the additional factors set forth in “Risk Factors” in Diplomat’s Annual Report on Form 10-K for the year ended Dec. 31, 2017, and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise.
Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payers, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.
CastiaRx is the industry’s leading specialty benefit manager. Combining full-service pharmacy benefit manager capabilities with specialty expertise, CastiaRx addresses spend across the benefit spectrum. The company leads with compassion, striving to simplify specialty management for its partners. Believe in better with CastiaRx—better treatment, better care, and a better path to a healthier future. For more information, visit castiarx.com.
|May 25, 2018||Excelera Members Benefit from Accreditation Measure Validation Services Provided...|
|May 11, 2018||Sentara RMH Medical Center Partners with Omnicell to Enhance Efficiency, Safety ...|
|May 11, 2018||Medi-Dose, Inc. / EPS, Inc. Announces Auxiliary Labels for Neuromuscular Blockin...|
|May 09, 2018||Jamco First to Achieve Updated FM Approvals|
|May 03, 2018||CriticalPoint Peer Network|
|May 01, 2018||Contec, Inc. Acquires Building in Spartanburg County Industrial Park|
|May 01, 2018||SynMed® ULTRA now installed in the US|
|Apr 30, 2018||Diplomat Launches CastiaRx, Industry-Leading Specialty Benefit Manager|
|Apr 30, 2018||RXinsider is proud to present The Compliance Team as a Thought Leader in Exempla...|
|Apr 23, 2018||Lewis Drug Awarded Exemplary Provider® Accreditation|
|Apr 17, 2018||25% OFF Pharmacy Software License Fee|
|Apr 04, 2018||TCGRx Announces the Acquisition Of ARxIUM’S Panasonic Fastpak Exp and Fastpak ...|
|Apr 04, 2018||Fagron Strengthens Strategic Position in USA Through Highly Complementary Acquis...|
|Mar 30, 2018||KeyCentrix appoints Luis Rodriguez as President|
|Mar 27, 2018||iMedicare Rebrands to Amplicare, a Decision-Automation Platform that Enables Hea...|
|Mar 27, 2018||Mercyhealth Adopts Omnicell’s XR2 Automated Central Pharmacy System to Enhance...|
|Mar 26, 2018||Washington State University Wins 8th Annual Student Pharmacist Compounding Compe...|
|Mar 26, 2018||H+H SYSTEM, Inc. USA Appoints Marketing Manager|
|Mar 22, 2018||CVS Health Appoints Derica W. Rice as President of CVS Caremark|
|Mar 19, 2018||MEDISCA Signs Out-Licensing Agreement with Torrey Hills Technologies for its Pro...|
|Mar 16, 2018||QS/1® Achieves Level 2 Capability for the Pharmacist Electronic Care Plan|
|Mar 14, 2018||SuiteRx a Pharmacy Owner's Dream|
|Mar 13, 2018||Introducing Mission Critical Delivery Solutions as a Thought Leader in Long Term...|
|Mar 09, 2018||Smith Drug Company Receives the 2018 Distribution Management Award for Cloud-Bas...|
|Mar 09, 2018||Albertsons Companies Earns URAC Accreditation in Specialty Pharmacy|
|Mar 06, 2018||Introducing AmerisourceBergen as a Thought Leader & Innovator in Pharmacy: Impro...|
|Mar 06, 2018||MHA Members WIN BIG with SuiteRx|
|Mar 02, 2018||Letco Medical, L.L.C. Announces Launch Of Innovative Education Value Program For...|
|Feb 26, 2018||J M Smith Corporation Announces Leadership Team Changes|
|Feb 26, 2018||Worz Named New ASCP Executive Director and CEO|
Connect with thousands of pharmacy professionals throughout every practice setting.